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Abstract
While aggregation-prone proteins are known to accelerate aging
and cause age-related diseases, the cellular mechanisms that
drive their cytotoxicity remain unresolved. The orthologous
proteins MOAG-4, SERF1A, and SERF2 have recently been identi-
fied as cellular modifiers of such proteotoxicity. Using a peptide
array screening approach on human amyloidogenic proteins, we
found that SERF2 interacted with protein segments enriched in
negatively charged and hydrophobic, aromatic amino acids. The
absence of such segments, or the neutralization of the positive
charge in SERF2, prevented these interactions and abolished the
amyloid-promoting activity of SERF2. In protein aggregation
models in the nematode worm Caenorhabditis elegans, protein
aggregation and toxicity were suppressed by mutating the
endogenous locus of MOAG-4 to neutralize charge. Our data
indicate that MOAG-4 and SERF2 drive protein aggregation and
toxicity by interactions with negatively charged segments in
aggregation-prone proteins. Such charge interactions might
accelerate primary nucleation of amyloid by initiating structural
changes and by decreasing colloidal stability. Our study points
at charge interactions between cellular modifiers and amyloido-
genic proteins as potential targets for interventions to reduce
age-related protein toxicity.
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Introduction
Protein homeostasis declines with aging (Lopez-Otın et al, 2013;
Walther et al, 2015; Stroo et al, 2017; Klaips et al, 2018). This
decline results in an increased accumulation of aggregation-prone
proteins, which accelerates aging and is associated with a wide range
of age-related disorders, including Alzheimer’s and Parkinson’s
diseases. Although the different proteins involved in these diseases
are usually unrelated in sequence and native structure, they share
the tendency to convert into ordered, cross-ß structures known as
amyloid fibrils (Serpell, 2000; DeMarco & Daggett, 2004; Tuttle et al,
2016). Structural conversions early in the aggregation process play
an important role in amyloid formation and the associated cellular
toxicity (Kayed & Lasagna-Reeves, 2012; Kim et al, 2016; Sangwan et
al, 2017). The cellular mechanisms that drive these early structural
conversions, however, are poorly understood, and uncovering them
is key for the development of interventions to prevent such toxic
structural changes in amyloid-associated diseases.
For several structurally unrelated amyloidogenic proteins, previ-
ous studies have identified proteins that enhance such structural
conversions, namely modifier of aggregation-4 (MOAG-4) in the
nematode worm Caenorhabditis elegans and its human orthologs
small EDRK-rich factors (SERF) 1A and 2 (Van Ham et al, 2010;
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Falsone et al, 2012; Yoshimura et al, 2017). In vitro studies with
purified proteins have shown that SERF1A preferentially promotes
the aggregation of amyloidogenic proteins—including alpha-
synuclein, amyloid beta, and prion protein—above the aggregation
of non-amyloidogenic proteins (Falsone et al, 2012). MOAG-4/
SERF1A is involved early on in the aggregation process. In the case
of alpha-synuclein, MOAG-4 and SERF hinder intermolecular inter-
actions within the protein, through electrostatic interactions (Yoshi-
mura et al, 2017; Merle et al, 2019). This results in a more
aggregation-prone conformation of alpha-synuclein, which in turn
seeds the formation of amyloid fibrils that can eventually form
large, insoluble aggregates (Falsone et al, 2012; Yoshimura et al,
2017; Merle et al, 2019). In addition, previous studies have shown
that MOAG-4 and SERF1A act transiently and are not incorporated
in amyloid fibrils themselves (Falsone et al, 2012; Yoshimura et al,
2017). The shared mechanism by which MOAG-4 and SERFs bind to
and induce the structural conversion of other amyloidogenic
proteins remains nevertheless unknown.
We therefore use a peptide array screening approach to identify
interactions between SERF2 and proteins in the hope that this would
give us insight into SERF2’s mechanism of action. Our findings
suggest that SERF2 affects the earliest steps of the aggregation
process by charge complementation on amyloidogenic proteins,
thereby inducing structural conversions that accelerate fibril forma-
tion.
Results
SERF2 selectively binds to negatively charged peptides
To determine how SERF catalyzes amyloid formation of multiple
unrelated amyloidogenic proteins, we first used a peptide
microarray-based approach to screen for SERF2-interacting amino
acid sequences. The microarray contained 12-mer peptide fragments
from 27 full-length parent proteins and four dipeptide repeat poly-
mers. Of these proteins, 19 have been classified as amyloidogenic,
though many proteins can form amyloids under the appropriate
conditions (Chiti & Dobson, 2017; Benson et al, 2019) (Appendix
Table S1, column A). Four of these amyloidogenic proteins, Abeta, α-
synuclein, huntingtin, and prion protein, have previously been shown
to functionally interact with SERF (Appendix Table S1, proteins
marked in bold) (Van Ham et al, 2010; Falsone et al, 2012; Merle et al,
2019; Meyer et al, 2020). The other proteins represented on the slide
included three other disease-related aggregation-prone proteins, four
disease-related dipeptide repeat polymers, a protein for which amyloid
formation is part of its physiological function, and four non-
amyloidogenic proteins (Appendix Table S1, columns B, C, D).
The full-length amino acid sequences for each of these proteins
were represented by 12-mer peptides that overlapped by eight resi-
dues, hence producing a sliding window over each protein sequence
(Fig 1A). The microarray contained duplicates of each peptide,
randomly distributed over the array (Fig 1A and Dataset EV1). Bind-
ing of ATTO633-labeled SERF2 (UniProt identifier P84101-1, 59
amino acids) was visualized by fluorescent laser scanning and
quantified based on fluorescence intensity (Dataset EV1). Peptides
were classified as SERF2 binders or non-binders based on their fluo-
rescence intensity relative to a set of glycine controls (Gly) (Fig 1B
and Dataset EV1). Therefore, in each of three repeat experiments,
the distribution of fluorescence intensities of the Gly control
peptides was assessed (Fig 1B, upper panels). For each experiment,
the cutoff was determined as the mean fluorescence of the Gly
control peptides plus twice their standard deviation (red dashed
lines in Fig 1B). In each separate repeat, peptides were then classi-
fied as binders when the RFU (relative fluorescence unit) values of
both duplicates on the array were higher than the cutoff value (Fig 1
B and Dataset EV1). Eventually, only peptides for which this was
the case in all three experiments were classified as actual binders
(Dataset EV2). Peptides with RFUs below the threshold in each
experiment were defined as non-binders, and peptides for which the
classification varies between repeats were classified as “ambigu-
ous”. In this way, 653 peptides were identified as binders, 2,333 as
non-binders, and 291 as ambiguous.
Next, we determined the relative abundance of each individual
amino acid in the group of SERF2 binding peptides compared with
non-binding peptides. For this comparison, the ratio between the
abundance of each amino acid in the group of binding peptides and
the abundance in the group of non-binding peptides was taken, yield-
ing a probability ratio (Dataset EV3). We then attributed an enrich-
ment score to each amino acid, by calculating the natural logarithm
of the probability ratio (Dataset EV3). This score was positive for
amino acids that were more abundant, and negative for amino acids
that were depleted in the group of SERF2-binding peptides (Fig 1C
and Dataset EV3). This analysis revealed a more than threefold over-
representation of the negatively charged amino acids aspartic acid
(Asp, D) and glutamic acid (Glu, E) in SERF2-bound peptides (ln
ratios of 1.23 for Asp and 1.50 for Glu; Fig 1C and Dataset EV3).
Conversely, when compared to their presence in non-bound
peptides, the positively charged amino acids lysine (Lys, K) and argi-
nine (Arg, R) were underrepresented in SERF2-bound peptides (ln
ratios of −1.09 for Arg and −1.56 for Lys; Fig 1C and Dataset EV3).
To make sure these results were not biased by our choice of (pre-
dominantly amyloidogenic) proteins represented on the microarray,
we compared the distributions of several general peptide character-
istics between the peptides on the microarray and all 12-mer
peptides derived from the human cytoplasmic proteome
(Appendix Fig S1). We found that the peptide set on the microarray
nicely covers the distributions of secondary structure propensities
(α-helical propensity, β-sheet propensity, and β-turn propensity), as
well as hydrophobicity and net charge.
Next, we assessed to what extent the cumulative amino acid
enrichment scores of the peptides, calculated as the sum of enrich-
ment scores of all amino acids composing that peptide, correlated
with their measured SERF2 binding intensities (Fig 1D and Dataset
EV2). As shown in Fig 1D, the cumulative enrichment scores corre-
late linearly to the natural logarithm of the actual binding signals (P-
value < 2e-16 and R2 of 0.82). This observation indicates that a
simple scoring function based solely on amino acid composition and
completely disregarding position-specific effects is sufficient to
predict binding of SERF2 to peptides. This therefore suggests that
SERF2 interaction does not require a strict binding motif. Further-
more, given that charged residues had the most extreme scores in
our scoring matrix (negatively charged amino acids scored highest
and positively charged amino acids scored lowest), SERF2 binding
appears to be mainly driven by net charge. To test this, we performed
a linear regression of the natural logarithm of the binding signals
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Figure 1. SERF2-interacting peptide sequences are enriched for negatively charged amino acids.
A Schematic representation of the peptide microarray screen. Green color represents autofluorescence of peptides at 532 nm.
B Histograms of the fluorescence intensities of wild-type ATTO633-labeled SERF2, bound to the peptides on the microarray in each of three independent repeats.
Fluorescence intensities for glycine (Gly) controls are marked in yellow (top panels). Red dashed line indicates cutoff between binders and non-binders. The
numbers of binders and non-binders identified in each experiment are indicated. Peptides are only classified as binders when both instances of the duplicate have
a higher RFU than the cutoff.
C Enrichment scores (ln(probability ratio)) of all amino acids in SERF2 binding (n = 653) versus SERF2 non-binding peptides (n = 2,333). Statistical significance was
determined through hypergeometric testing with the Bonferroni correction for multiple comparisons. *P < 0.05, ***P < 0.001, and ****P < 0.0001.
D, E Correlation of the natural logarithm of mean wild-type SERF2 binding intensities (background-corrected per experiment) with the cumulative amino acid
enrichment scores (D) or net charge (E) of the microarray peptides. Mean RFU was transformed as ln(meanRFU − min(mean RFU) + 1). Linear regression curve, R2,
P-value as determined through a t-test, and number of binders, non-binders, and ambiguous peptides are indicated.
F Receiver operating characteristic (ROC) curves of binder prediction based on cumulative score (blue) or net charge (brown). ROC curve shows fractions of true-
positive and false-positive predictions on y- and x-axes respectively, with increasing cutoff values. The area under the curve (AUC) is indicated for both cumulative
score and net charge and constitutes a metric for the predictive power of the statistic (cumulative score or net charge). Optimal cutoffs are indicated.
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versus net charge (Fig 1E). This also showed a strong correlation (P-
value < 2e-16), which confirmed that net charge is indeed a key
driver for SERF2 binding. To rule out overfitting of the enrichment
scores by basing them on the entire dataset, we recalculated the
enrichment scores using just 70 percent of the data, which consti-
tutes our training set (Appendix Fig S2A), and tested the correlations
on the remaining 30 percent (Appendix Fig S2B and C), with practi-
cally identical results. In both calculation methods, the regression
based solely on net charge has a lower R2 than the regression based
on the cumulative enrichment score (0.717 versus 0.82, respectively,
in Fig 1E) because of a stronger degree of scatter around the regres-
sion line, indicating that the cumulative enrichment is a more accu-
rate predictor of SERF2 binding than net charge alone. To confirm
this, we plotted receiver operating characteristic (ROC) curves for
both predictors (cumulative score and net charge; Fig 1F). In a ROC
curve, the fraction of correct binary classifications or “true-positive
fraction” (SERF2 binder or non-binder) at each threshold of the
predictor (either net charge alone or cumulative enrichment score) is
plotted against the fraction of false classifications (“false-positive
fraction”). The area under the curve (AUC) gives an indication of the
performance of the predictor at the classification problem, in this
case, classifying peptides into SERF2 binders or non-binders.
Although both net charge and cumulative enrichment score show
strong predictive power, the cumulative score outperforms net
charge (AUC of 0.99 versus 0.96). These results corroborate that net
charge seems a key driver of SERF2 interaction, but that likely also
non-charged amino acids affect binding intensity.
To next profile the SERF2 binding sites to each protein on the
microarray, we mapped the binding intensities of each peptide to its
corresponding position in its full-length parent protein (Fig 2). Due
to the sliding window design of our microarrays, we were able to
obtain a SERF2 binding profile by averaging the binding intensities of
each of the three peptides that contained a particular residue (Dataset
EV4). This yielded a binding profile with a resolution of four amino
acids (Fig 2 and Appendix Fig S3A). To further explore the link
between net charge and SERF2 binding, we similarly produced net
charge profiles for all the proteins under study (Dataset EV4 and
Appendix Fig S3B), this time averaging the net charges of the three
peptides in which a residue is represented (Fig 2 and Appendix Fig
S3B). This analysis again showed a strong association between
SERF2 binding and local negative net charge. Strikingly, while both
positively and negatively charged regions are present in the majority
of the proteins, all of the proteins analyzed here contain at least one
strong negatively charged SERF2 binding site, with the exception of
one amyloid-forming protein—human islet amyloid polypeptide
(hIAPP); the four dipeptide repeat polymers (poly-GR, poly-PR, poly-
GA, and poly-PA); and SERF2 itself. Interestingly, despite the strong
correlation observed between SERF2 binding and local net charge,
we also observed strong variations in binding intensities among
peptides with identical net charges (Figs 1E and 2). For example, a
clear interaction between SERF2 and a negatively charged region in
prion protein around position 150 was observed, while the SERF2
binding intensities were much lower for the two similarly charged,
neighboring regions in this protein (Fig 2 and Appendix Fig S3A).
This again indicated that besides charge, additional sequence proper-
ties contributed to the strength of the interactions.
We therefore asked whether there was an overlap between
SERF2 binding sites and regions predicted to drive the aggregation
of their parent proteins. These regions were predicted using the
Tango and Waltz algorithms, which identify aggregation-prone and
amyloidogenic regions, respectively (Fernandez-Escamilla et al,
2004; Maurer-Stroh et al, 2010). However, no clear overlap could be
observed (Appendix Fig S4).
To assess whether the relative binding patterns observed in the
microarray—in which peptides are physically fixed to the array—
hold in solution, we performed microscale thermophoresis (MST)
analyses with three peptides derived from alpha-synuclein, a protein
previously shown to interact with SERF2, using peptides that span a
range of fluorescence intensities on the microarray: the peptide with
the highest fluorescence intensity (Asyn top, YEMPSEEGYQDY), one
with intermediate fluorescence intensity (Asyn Med; GKNEEGAP-
QEGI), and the alpha-synuclein-derived peptide with the lowest flu-
orescence intensity (Asyn worst; MDVFMKGLSKAK). The data in
Appendix Fig S5A show that in solution, Asyn med binds with
lower affinity than Asyn top and Asyn worst with lower affinity still.
These data provide some preliminary evidence that the relative
patterns observed on the microarray hold in solution.
SERF2 binding is further enhanced by hydrophobic, aromatic
residues
To identify other sequence features that influenced the interactions
of the peptides with SERF2, we focused on the subset of binding
peptides for which the actual binding intensities differed strongly
(more than two standard deviations over the mean difference) from
the predicted intensity based on the cumulative enrichment scores
(77 peptides; Fig 3A and Dataset EV2). We compared the amino acid
composition of these peptides with all other binding peptides
(Dataset EV5). This analysis revealed a strong enrichment for the
hydrophobic, aromatic residues tyrosine (Tyr, Y) and phenylalanine
(Phe, F) and the hydrophobic amino acids valine (Val, V) and
leucine (Leu, L), suggesting a role for these amino acids in interac-
tions with SERF2 (Fig 3B). Taken together, these findings indicate
that the interaction between charged residues and SERF2 is further
enhanced by the presence of hydrophobic residues.
The positively charged N-terminus of SERF2 mediates binding
SERF2 is a highly positively charged protein that has a net charge of
+10, mainly due to a region in its N-terminus that is evolutionarily
highly conserved (Appendix Figs S6A and B). To assess the role of
this region in the charge-based interactions between SERF2 and
amyloidogenic proteins, we neutralized the net charge of +5 in this
region by inducing point mutations in the three positively charged
amino acids, Lys16, Lys17, and Lys23 (Fig 4A). To exclude the possi-
bility of the charge mutations resulting in structural changes relative
to the wild-type protein, the secondary structure of both proteins
was assessed with Fourier transform infrared spectroscopy (FTIR,
Appendix Fig S6C). These measurements revealed the structures of
both the wild-type and charge mutant SERF2 proteins to be largely
disordered: Their random coil content was estimated to be over
80% as calculated by peak intensity ratios. This indicates that the
charge mutations did not induce major changes in the secondary
protein structure (Appendix Fig S6C).
We then tested the ability of the SERF2 charge mutant protein to
interact with the peptides on the microarray, and observed that the
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Figure 2. SERF2 binding maps to net negatively charged regions.
Overview of binding sites for SERF2 in proteins represented on the microarray slide. Average net charge and binding of SERF2 (see Dataset EV4 for values) in each protein
are indicated.
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number of peptides to which it bound (Fig 1A and Appendix Fig
S6D) was lower than the number of peptides bound by wild-type
SERF2 (Fig 1B) in each experiment. Furthermore, the number of
peptides to which it bound reproducibly across three experiments
(317 peptides) was less than half of the number of wild-type SERF2-
bound peptides (653 peptides) (Dataset EV2). Although both wild-
type and charge mutant SERF2 binding signals showed a significant
correlation with net charge, this correlation was much stronger for
wild-type SERF2 than for the SERF2 charge mutant (regression
slopes of −0.34 and −0.053, respectively; Fig 4B and Appendix Fig
S6E). The possibility that higher binding intensities were measured
for fluorescently labeled wild-type SERF2 than for charge mutant
SERF2 due to the presence of multiple fluorescent labels on wild-
type SERF2 was excluded by mass spectrometry (Appendix Fig S6F–
I). We further confirmed the reduced affinity of the SERF2 charge
mutant in solution through MST analyses (Appendix Fig S5A and
B). These analyses show binding affinity of the SERF2 charge
mutant to the alpha-synuclein peptides is severely reduced
compared with wild-type SERF2.
Altogether, these results are in line with previous biochemical
and NMR indications that charge interactions are a major mediator
of the interaction between MOAG-4 or SERF1A and alpha-synuclein,
and that the positively charged N-terminus of MOAG-4 or SERF1A is
involved in these interactions (Yoshimura et al, 2017; Merle et al,
2019). Furthermore, the finding that hydrophobic, aromatic residues
were enriched in the strongest SERF2 binding peptides (Fig 3B)
suggests that on top of charge–charge interactions, also cation–pi
interactions between positively charged residues in the SERF2 N-
terminus and the aromatic residues of substrate peptides might
mediate SERF2–substrate interactions.
SERF2 promotes amyloid formation through its positively
charged N-terminus
Now, our data indicate that charge is an important factor in interac-
tions between amyloidogenic proteins and SERF2, and we next aimed
to determine the functional consequences of these interactions for
amyloid catalysis. Previous work identified the C-terminus of alpha-
synuclein as the interaction site for MOAG-4 and SERF1A (Falsone et
al, 2012; Yoshimura et al, 2017; Merle et al, 2019). In line with this
observation, our peptide microarray screen revealed that wild-type
SERF2 also interacts with the acidic C-terminal region of alpha-
synuclein, as well as with the negatively charged N-terminal region of
amyloid beta (Fig 5A and B). Previous reports have shown that both
these regions are important for the solubility of these proteins (Ber-
toncini et al, 2005; Wildburger et al, 2017; Sorrentino et al, 2018). To
test whether the binding of SERF2 to the negatively charged regions of
alpha-synuclein and amyloid beta promotes amyloid formation of
these proteins, we compared the in vitro aggregation kinetics of puri-
fied alpha-synuclein and amyloid beta in the presence and absence of
wild-type or the charge mutant SERF2 using well-established thioflavin
T (ThT) fluorescence assays. These experiments confirmed previous
experiments showing that the formation of both alpha-synuclein- and
amyloid beta ThT-positive species was accelerated in the presence of a
wild-type SERF protein (Fig 5C and D, and Dataset EV6). Equimolar
amounts of SERF2 with alpha-synuclein strongly reduced the initial lag
phase, and the half-time of conversion was reduced by about 60%
(Fig 5C and Appendix Fig S7A, and Dataset EV6). In addition, both the
initial lag phase and midpoint of amyloid growth for amyloid beta
aggregation were reduced by about 30% in the presence of SERF2
(Fig 5D and Appendix Fig S7B and Dataset EV6). In contrast, the
SERF2 charge mutant did not accelerate the amyloid formation of
alpha-synuclein and amyloid beta. These results indicate that the posi-
tively charged region of SERF2 is required for its amyloid-promoting
effect, which is mediated by the negatively charged regions in
amyloidogenic proteins.
To further challenge that SERF2 only has an amyloid-promoting

















































Figure 3. Peptide sequences enriched for hydrophobic, aromatic amino
acids show enhanced SERF binding.
A Reiteration of Fig 1D, with peptides for which the transformed fluorescence
intensity deviates strongly from the predicted value indicated.
B Enrichment scores (ln(probability ratio)) of all amino acids in SERF2-binding
peptides for which the transformed fluorescence intensity deviates strongly
from the predicted value (n = 77), versus the remaining SERF2 binding
peptides (n = 4,583). Statistical significance was determined through
hypergeometric testing with Bonferroni correction for multiple
comparisons. *P < 0.05 and ****P < 0.0001.
A B
Figure 4. Positively charged N-terminus of SERF2 mediates binding.
A Mutations and average net charge distribution in the wild-type SERF2 and
SERF2 charge mutant.
B Correlation between wild-type SERF2 and SERF2 charge mutant binding
intensities versus peptide net charge. Mean RFU was transformed as ln
(meanRFU – min(mean RFU) + 1). Pearson’s correlation coefficients (R), P-
value as determined through a t-test, and linear regression equations are
indicated.
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amyloidogenic protein, we turned to our peptide microarray screen
and selected a peptide for which no interaction with either wild-type
SERF2 or the SERF2 charge mutant had been identified, namely
hIAPP (Figs 2 and 5E). hIAPP is a predominantly positively charged
peptide with strong amyloid-forming properties, which is why we
chose this peptide to perform a ThT assay in the presence and
absence of wild-type or charge mutant SERF2. This experiment
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an effect on hIAPP amyloid aggregation (Fig 5F and Appendix Fig
S7C, and Dataset EV6). Taken together, these data support our
finding that electrostatic interactions between SERF and amyloido-
genic proteins are required to allow SERF to catalyze amyloid
formation.
Charge interactions are required for SERF to drive protein
aggregation in cells
Our data suggest a role for SERF2 as an amyloid-promoting factor
through interactions with negatively charged regions on amyloido-
genic proteins. Because negatively charged regions are present in a
large fraction of the proteome, we wanted to know whether this
mechanism also applies in the context of the full proteome of a
human cell. Therefore, we generated a SERF2 CRISPR deletion
mutant HEK293T cell line (Appendix Fig S7D–H) and tested whether
adding wild-type and charge mutant SERF2 to these cells affected
the aggregation of an aggregation-prone model substrate (Fig 5G).
The substrate we chose was an HA-tagged mutant Huntington exon
1 (HTTex1) fragment protein with 74Q repeats. In previous experi-
ments, HTTex1 HA-Q74 has shown robust and strong aggregation in
cells, which can be modified by several cellular factors, including
SERF1A and SERF2 (Narain et al, 1999; Van Ham et al, 2010). The
HA-tag, also found to bind SERF2, adds a net negative charge to the
N-terminal site of the mutant HTTex1 fragment protein (Fig 5G and
Appendix Fig S7I and J). The HTTex1 HA-Q74 fragment protein was
therefore a model protein that combined the elements that we had
identified as being essential for interactions with SERF2 with an
effective aggregation-prone region. Moreover, this model protein
allowed us to determine the contribution of electrostatic interactions
between SERF and its client proteins to catalyze protein aggregation
in the cell, independent of other cellular factors. Note that we used
HTTex1 in this context as a synthetic amyloidogenic polyglutamine
peptide, rather than as a model for Huntington’s disease.
We first determined whether the positive charge of SERF2 was
required to interact with the HA-tag. Therefore, a Filter Trap assay
was performed using cell lysates from the SERF2 deletion mutant
cell lines that expressed wild-type SERF2, the SERF2 charge mutant,
or a SERF2 control mutant, in combination with the HTTex1 HA-
Q74 fragment protein. A SERF2 control mutant, with substitutions
in three uncharged amino acids to alanine (Ala) in the same
domain, was added to exclude the possibility that mutations in the
N-terminal region of SERF2 other than mutations in charged amino
acids might be able to diminish the effect of SERF2 on aggregation
(Fig 5H). We found that Q74 aggregation was lower when co-
expressed with the SERF2 charge mutant (Fig 5I and Appendix Fig
S7L) than with the wild-type SERF2 or the SERF2 control mutant
protein (Fig 5J and Appendix Fig S7M). The mutations did not
change the localization of the SERF2 charge mutant in the cell when
compared to the wild-type protein (Appendix Fig S7K). These
results confirmed a role for the positively charged N-terminal amino
acids of SERF2 in driving aggregation in human cells.
To further establish the role of charge interactions between
SERF2 and the HA-Q74 protein, we also generated a mutated
version of the HA-Q74 substrate. Mutations in the HA-tag were
induced by substituting two negatively charged Asp residues for the
neutrally charged amino acid Ala, resulting in a net neutral charge
for the HA-tag (Fig 5G). The HA-Q74 and muHA-Q74 constructs
were overexpressed in SERF2 CRISPR deletion mutant cells in
combination with either wild-type SERF2 or the SERF2 charge
mutant, and a Filter Trap assay was performed. This experiment
revealed that neither wild-type SERF2 nor the SERF2 charge mutant
could affect the amount of muHA-Q74 aggregation (Fig 5K and
Appendix Fig S7N).
The results obtained using this model suggest that SERF2 can
trigger aggregation through specific and direct electrostatic interac-
tions with charged regions of aggregation-prone proteins, indepen-
dently of other modifying factors present in the cell.
Charge mutations in MOAG-4 reduce aggregation in C. elegans
Our in vitro results showed that charge mutations in the positively
charged N-terminal region of SERF2 could abolish the amyloid-
promoting effect of SERF2. We then wanted to determine whether
this also applied in the context of a full-body organism. We there-
fore introduced charge mutations into the C. elegans ortholog of
◀ Figure 5. SERF2 drives amyloid formation via charge interactions.
A, B Net charge distribution (black) of αSyn (A) and Aß (B), plotted together with the binding distribution of wild-type SERF2 (blue) and the SERF2 charge mutant (red).
Blue boxes represent the SERF2-interacting regions.
C ThT-monitored amyloid kinetics of 50 μM alpha-synuclein in the presence of either wild-type SERF2 or mutant SERF2 in a 1:1 ratio. The average of three biological
replicates is represented, and error bars indicate mean  SD. Normalized aggregation data in Appendix Fig S7A.
D ThT-monitored amyloid kinetics of 1 μM amyloid beta in the presence of either wild-type SERF2 or mutant SERF2 in a 1:4 ratio. The average of four technical
replicates is represented, and error bars indicate mean  SD. Normalized aggregation data in Appendix Fig S7B.
E Net charge distribution of hIAPP (black), plotted together with the binding distribution of wild-type SERF2 (blue) and the SERF2 charge mutant (red).
F ThT-monitored amyloid kinetics of 2 μM human islet amyloid polypeptide in the presence of either wild-type SERF2 or mutant SERF2 in a 1:4 ratio. The average of
five technical replicates is represented, and error bars indicate mean  SD. Normalized aggregation data in Appendix Fig S7C.
G Model and charge distribution graph of HA-Q74 and muHA-Q74 constructs.
H Mutations and charge distribution in the SERF2 control mutant and SERF2 charge mutant proteins.
I–K Filter Trap with fivefold serial dilution and quantification of crude protein extract from SERF2 CRISPR deletion mutant cells transiently transfected with HA-
polyQ74 and either wild-type SERF2, empty vector, or SERF2 charge mutant (I); wild-type SERF2, empty vector, or SERF2 control mutant (J); or transfected with
muHA-Q74 and either wild-type SERF2, empty vector, or SERF2 charge mutant. Western blots for HA-Q74, muHA-Q74, SERF2, and tubulin expression were included
as controls (see Appendix Fig S7L–N for quantification). For all Filter Trap assays, the depicted blots are from one representative experiment of four biological
replicates. The average of four biological replicates with each three or four technical replicates is represented in the graphs. Data are represented as mean  SD,
and significance was calculated using a one-way ANOVA, followed by a post hoc Bonferroni multiple comparisons test. (I) P < 0.0001, (J) P = 0.0003, and (K)
P = 0.9130. **P < 0.01 and ***P < 0.001.
Source data are available online for this figure.
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SERF2, MOAG-4, to see whether this would suppress aggregation in
a C. elegans model of protein aggregation. We used CRISPR to
induce point mutations in the endogenous locus of the moag-4 gene
to change the exact same amino acids as previously done for SERF2
(Fig 6A and Appendix Fig S8A). The MOAG-4 charge mutant and
MOAG-4 control mutant strains were crossed with a polyglutamine
(polyQ) worm model (Q40). Cells in the body-wall muscle of the
Q40 worm express a transgene carrying an aggregation-prone polyQ
stretch of 40 residues, fused C-terminally to yellow fluorescent
protein (YFP; Appendix Fig S8B) (Van Ham et al, 2010; Sin et al,
2017). The effect of the point mutations in MOAG-4 was determined
by quantifying the number of aggregates in the worms in the fourth
larval stage (L4). As previously reported, genomic deletion of
MOAG-4 (MOAG-4 del) strongly reduces the number of aggregates
(Van Ham et al, 2010). Here, we also saw that the number of aggre-
gates in worms carrying mutations in positively charged amino
acids at the N-terminus of MOAG-4 was much lower—by about
60%—than the numbers seen in wild-type Q40 worms or worms
expressing the MOAG-4 control mutant (Fig 6B and C, and
Appendix Fig S8C–E). Based on the peptide arrays, we do not expect
MOAG-4 to bind to the polyglutamine part of Q40-YFP. Whether it
interacts with charged residues in flanking regions, as observed for
SERF2, or acts indirectly via other molecules in the cell remains to
be determined. To corroborate these results, we employed a second
amyloid model strain, JKM2, expressing the aggregation-prone
amyloid beta peptide of 42 amino acids length (Aβ1-42) that is associ-
ated with Alzheimer’s disease (Gallrein et al, 2021). Respective
crosses with the MOAG-4 deletion, control, and charge mutant
strains were generated to address the in vivo impact of MOAG-4 on
Aβ1-42 aggregation and toxicity. The Aβ1-42 aggregation was assessed
in live animals employing fluorescence lifetime microscopy (FLIM)
(Fig 6D and Dataset EV7). We found that aggregation of Aβ1–42 in
the retrovesicular ganglion is significantly reduced in the MOAG-4
deletion and charge mutant background, but not in the control
mutant compared with the parental Aβ1–42 strain (Fig 6E and
Dataset EV7). This indicates that MOAG-4 also affects the aggrega-
tion of different amyloid proteins by a charge-dependent mecha-
nism. Next, we wanted to explore whether the decreased Aβ1–42
aggregation in the MOAG-4 charge mutant animals translates into a
reduced Aβ1–42 toxicity. First, we analyzed the lifespan as read-out
for the general vitality of Aβ1–42 animals that are short-lived
compared with wild-type animals. We observed a significantly
increased lifespan for the MOAG-4 charge mutant cross compared
with the MOAG-4 control mutant cross (Fig 6F and Dataset EV7). In
the absence of Aβ1-42-co-expression, MOAG-4 control and charge
mutant did not change nematode lifespan (Fig 6F and Dataset EV7),
indicating that a charge reduction in MOAG-4 reduced the toxic
effect of Aβ1–42 on lifespan. Since MOAG-4 was observed to be
involved in regulating early aggregation steps (Yoshimura et al,
2017; Merle et al, 2019), we wondered whether larval stage nema-
todes that did not exhibit aggregate formation (Gallrein et al, 2021)
would be influenced by charge mutation in MOAG-4. Interestingly,
while expression of Aβ1–42 induced a delay in development, this
retardation was partially rescued in the MOAG-4 charge mutant
background, but not by the MOAG-4 control mutant (Fig 6G and
Dataset EV7). In the absence of Aβ1–42, both MOAG-4 control and
charge mutant again did not affect the development. These data
would support the idea that MOAG-4 influences early toxicity of
Aβ1–42 as well, even before aggregates become apparent. Finally, we
tested the effect of the MOAG-4 charge mutant in an assay reporting
on the neuronal activity of animals. For that, we employed a
pathogen avoidance assay that relies on intact URY neurons. As
demonstrated previously, URY neurons are compromised in Aβ1–42
animals, resulting in an inability to avoid pathogenic Serratia
marcescens bacteria (Gallrein et al, 2021). Notably, we found that
the MOAG-4 charge mutant, but not MOAG-4 control mutant, could
partially rescue pathogen avoidance in Aβ1–42 animals (Fig 6H and
Dataset EV7). As expected, the behavior toward non-pathogenic E.
coli bacteria was unaltered in any mutant background. Altogether,
our data reveal that the charge of endogenous MOAG-4 is responsi-
ble for its proteotoxic activity in C. elegans.
Charge rather than amino acid composition of MOAG-4/SERF
drives binding to amyloidogenic proteins and aggregation
Our data indicate that the positive charge in the N-terminus of
SERF2 is required for interactions with amyloidogenic proteins and
for subsequent acceleration of amyloid formation. To confirm that it
is indeed the positively charged nature of Lys16, Lys17, and Lys23 in
SERF2 that is responsible for this ability and not any other lysine-
specific characteristic, we created a lysine-to-arginine SERF2 mutant
(KR mutant; Fig 7A). The K-to-R mutations do not alter the charge
of the SERF2 protein. To investigate whether the KR mutations
change the affinity of SERF2 to previously identified strong binders
of SERF2 in alpha-synuclein and amyloid beta (Dataset EV2, peptide
numbers 61 and 0), we measured their binding affinities using
microscale thermophoresis (MST). MST can determine the binding
affinity of a fluorescently labeled molecule to a potential ligand by
monitoring the movement of fluorescent molecules through a micro-
scopic temperature gradient. This revealed that at low ionic
strength, wild-type SERF2 and the SERF2 KR mutant have similar
binding affinities for the alpha-synuclein peptide (KD = 3 μM and
2.6 μM, respectively; Fig 7B and D) and for the amyloid beta peptide
(KD = 9.6 μM and 6.6 μM, respectively; Fig 7C and D). Moreover,
relative in-solution binding to the “Asyn med” and “Asyn worst”
peptides was confirmed to be nearly identical for the SERF2 KR
mutant and wild type (Appendix Fig S5). In contrast, the binding
affinities for the SERF2 charge mutant with the alpha-synuclein and
amyloid beta peptides are substantially lower (KD = 56 μM and
182 μM, respectively; Fig 7B–D). These data support our hypothesis
that charge complementation drives the interactions between SERF2
and substrate proteins, and indicate that no property of lysine, other
than its positive charge, is required for these interactions.
Additionally, we tested whether the aggregation-promoting abil-
ity of the KR mutant also remained in our C. elegans model for
polyQ aggregation. Therefore, we crossed a CRISPR-induced moag-4
KR mutant strain with our Q40 worm model and quantified the
number of aggregates in the body-wall muscle of the worms (Fig 7E
and F and Appendix Fig S9A–D). Here, we found that the number of
aggregates in the worms expressing the KR mutant was not different
from the amount of aggregates found in the body-wall muscle of
worms expressing wild-type MOAG-4 (Fig 7F and Appendix Fig
S9B–D). In summary, these data show that SERF2 and MOAG-4
retain their amyloid-promoting properties when lysines are substi-
tuted by arginines and therefore that charge is the driving force for
the interactions between SERF2 and amyloidogenic proteins.
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Discussion
While SERF has been identified as an enhancer of protein toxicity
and amyloid aggregation for a range of unrelated amyloidogenic
proteins, a shared underlying mechanism had not yet been
investigated (Van Ham et al, 2010; Falsone et al, 2012; Yoshimura
et al, 2017). Here, we found that SERF2 binds preferentially to nega-
tively charged amino acids and that this binding and its catalyzing
effect on amyloid formation required SERF2’s evolutionarily
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particularly excited to find that neutralizing the charge in the
endogenous locus of MOAG-4 in C. elegans strongly reduced the
aggregation of a reporter substrate, which suggests that neutralizing
the charge of a single protein in the cell’s proteome is sufficient to
alter proteome stability. In the C. elegans integrated dataset from
the PaxDB (Wang et al, 2015), MOAG-4 is listed at 387 ppm, which
puts it in the top 5% most abundant proteins identified. For SERF2,
these levels range from 0.54 till 413, depending on the cell lines in
which the concentrations have been measured. In comparison, C.
elegans small heat-shock protein 12.1—member of a class of chaper-
ones for which substrate KDs have been reported in the low micro-
molar range (Bruinsma et al, 2011; Shammas et al, 2011; Freilich
et al, 2018)—has an abundance of 380 ppm. These comparable
levels support the relevance of the low-affinity interactions between
MOAG/SERF and the substrate proteins that we observed in our
cell-free experiments.
Previous studies have described how the processes involved in
guiding unfolded proteins toward their properly folded state—and
keeping them in this native state—rely on charged residues (Xiao &
Honig, 1999; Gribenko & Makhatadze, 2007; De Baets et al, 2014;
Sant’Anna et al, 2014; Houben et al, 2020). The charge of proteins
is affected by numerous factors, including mutations, changes in
pH, post-translational modifications, and external stress (Adav et al,
2016; de Graff et al, 2016; Munder et al, 2016). In addition, other
modifying factors, such as charged polymers, are known to promote
amyloid fibril formation. For example, polyanions such as
glucosaminoglycans (i.e., heparin), nucleic acids, and polyphos-
phate (polyP), as well as positively charged polylysines and
polyamines, were recognized to interact with oppositely charged
regions, compensating their charge and promoting amyloid forma-
tion (Wickramasinghe et al, 2019; Calamai et al, 2006; Nandi et al,
2002; Cohlberg et al, 2002; Goers et al, 2003; Bertoncini et al,
2005). These factors can thereby lead to excessive unfolding and
exposure of unprotected aggregation-prone regions. When the abun-
dance of unfolded proteins exceeds the capacity of the cellular
protection mechanisms, these unfolded proteins become susceptible
to off-pathway structural conversions that drive them into thermo-
dynamically highly stable amyloid fibrils (Goldschmidt et al, 2010;
Chiti & Dobson, 2017; Yang et al, 2018; Hinderhofer et al, 2019).
Our findings suggest that cellular modifiers such as SERF may simi-
larly accelerate protein transitions to amyloid by acting on the
protein’s charge.
Most of what is known about SERF’s mechanism of action comes
from studies on alpha-synuclein. Alpha-synuclein is a natively
unstructured protein that remains soluble through a strong interac-
tion between its acidic C-terminal and its N-terminal region, an
interaction that shields its aggregation-prone middle region (Ber-
toncini et al, 2005; Hong et al, 2011; Sorrentino et al, 2018). Factors
that can disrupt these electrostatic intermolecular interactions, such
as high salt concentrations (Yoshimura et al, 2017), polyamine
compounds (Bertoncini et al, 2005), metal cations (Uversky et al,
2001), or C-terminal truncations (Li et al, 2005; Falsone et al, 2012),
have been shown to enhance alpha-synuclein aggregation. In previ-
ous nuclear magnetic resonance spectroscopy studies, positively
charged residues in the N-terminus of SERF1A or MOAG-4 were
found to interact with the amino acids in the C-terminal region of
alpha-synuclein (Falsone et al, 2012; Yoshimura et al, 2017). This
interaction exposes an amyloid nucleation site on alpha-synuclein
that is otherwise concealed by intermolecular interactions (Merle et
al, 2019). A direct but transient interaction between SERF and
alpha-synuclein has been confirmed by overexpression of SERF1A
and alpha-synuclein in SHSY-5Y neuroblastoma cells (Merle et al,
2019). Interestingly, the interactions between alpha-synuclein and
SERF1A or its yeast ortholog ScSERF have been shown to result in
the formation of a fully disordered protein complex, which acceler-
ates the primary nucleation of alpha-synuclein amyloid formation
(Borgia et al, 2018; Meinen et al, 2019; Merle et al, 2019). Our find-
ings are in line with these observations and suggest that also SERF2
might accelerate primary nucleation of alpha-synuclein amyloid
formation through charge complementation.
Here, we observed a similar effect of SERF2 on amyloid beta. In
amyloid beta, the strongest negative charge is located in the N-
◀ Figure 6. Neutralizing charge of the endogenous SERF ortholog MOAG-4 is sufficient to suppress protein aggregation and toxicity in C. elegans.
A Mutations and average net charge distribution of wild-type MOAG-4, MOAG-4 charge mutant, and MOAG-4 control mutant.
B Representative images of Q40 and Q40; moag-4 charge mutant animals. Scale bar, 75 mm.
C Representative quantification of the number of aggregates in Q40 worms with moag-4 deletion or expression of either wild-type moag-4, moag-4 charge mutant, or
moag-4 ctrl mutant. The results shown are representative experiments of three biological replicates of n = 20 worms in L4 stage. Data are represented as
mean  SD, and significance was calculated using a one-way ANOVA, followed by a post hoc Bonferroni multiple comparisons test. ****P < 0.0001.
D Representative TCSPC-FLIM images from the indicated strains. The dashed lines mark the retrovesicular ganglion, and arrowheads indicate aggregates. Scale bar is
50 µm.
E Number of aggregates per retrovesicular ganglion from three independent cohorts of the indicated Aβ1–42 strains with moag-4 deletion mutant (del (tm4909)),
n = 11; moag-4 control mutant (ctrl mutant), n = 12; moag-4 charge mutant (charge mutant), n = 17; and wild type, n = 15. Data are represented as mean  SD.
Significance was tested by one-way ANOVA followed by the Bonferroni post hoc test. *P < 0.05 and ****P < 0.0001.
F Cumulative survival probability of the indicated strains (N2: n = 120; Aβ1–42: n = 120; moag-4 control mutant (ctrl mutant): n = 105; moag-4 control mutant; Aβ1–42
(ctrl mutant; Aβ1–42): n = 95; moag-4 charge mutant (charge mutant): n = 100; moag-4 charge mutant; and Aβ1-42 (charge mutant; Aβ1-42): n = 90). Significance was
tested by the Mantel–Cox test. **P < 10−4 and ***P < 10−6.
G Fractions of nematodes in the indicated developmental stages after three days at 20°C starting from egg laying. Aβ1–42: ℕ = 6 (analyzed cohorts), n = 16–78 (animals
per cohort); ctrl mutant: ℕ = 3, n = 42–191; ctrl mutant; Aβ1-42: ℕ = 6, n = 34–70; charge mutant: ℕ = 3, n = 46–139; charge mutant; Aβ1-42: ℕ = 6, n = 26–125.
Depicted significance was tested between L4-stage groups with ANOVA followed by the Bonferroni post hoc test. ***P < 0.001. Depicted is mean  SD.
H Pathogen avoidance reaction of indicated nematode strains from Serratia marcescens Db11 or Escherichia coli OP50. Dots represent a single cohort (10–15 individual
animals/cohort), bars display mean across cohorts  SD. S. marcescens Db11–N2: ℕ = 11 (cohorts), N = 3 (experimental runs), n = 4 (technical replicates); Aβ1-42:
ℕ = 7, N = 2, n = 4; to l-1 mutant: ℕ = 9, N = 3, n = 4; ctrl mutant: ℕ = 7, N = 2, n = 4; ctrl mutant; Aβ1–42: ℕ = 7, N = 2, n = 4; charge mutant: ℕ = 8, N = 2,
n = 4; charge mutant; Aβ1–42: ℕ = 7, N = 2, n = 4. Significance was tested with ANOVA followed by the Bonferroni post hoc test. ***P < 0.001. E. coli OP50—N2:
ℕ = 8, N = 3, n = 4; Aβ1–42: ℕ = 7, N = 2, n = 4; tol-1 mutant: ℕ = 8, N = 3, n = 4; ctrl mutant: ℕ = 5, N = 2, n = 4; ctrl mutant; Aβ1–42: ℕ = 6, N = 2, n = 4; charge
mutant: ℕ = 5, N = 2, n = 4; charge mutant; Aβ1–42: ℕ = 6, N = 2, n = 4.
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terminal region of the protein. Interaction of SERF2 with amyloid
beta appears to take place at this charged region: When we added
SERF2 to amyloid beta in kinetic assays, we saw that SERF2
required this charge interaction to accelerate aggregation. Recent
studies have shown that it is the N-terminus of the amyloid beta
peptide that determines its tendency to aggregate. Indeed, N-
terminal mutations that affect the charge of this region are known to
modify amyloid beta fibril formation. Such mutations include amino
acid changes (Viet et al, 2013; Xu et al, 2014), post-translational
modifications (Kummer & Heneka, 2014), and truncations of the
protein (Dammers et al, 2017; Scheidt et al, 2017; Wildburger et al,
2017; Moro et al, 2018). In addition, a number of residues in the N-
terminus of amyloid beta can bind metal cations—including Cu2+
and Zn2+—which also accelerate amyloid beta aggregation through
mechanisms that are currently unresolved (Danielsson et al, 2007;
Talmard et al, 2007; Faller, 2009; Yugay et al, 2016). Given the fact
that charge is a common denominator in all of these modifying
factors, mechanisms similar to those observed for MOAG-4/SERF
may well explain their amyloid-promoting effect.
As mentioned above, our findings are in line with the previous
binding site, namely amino acids 6 to 28 of MOAG-4 and SERF1A
for their aggregation-promoting effects on alpha-synuclein (Yoshi-
mura et al, 2017; Merle et al, 2019). However, besides the previ-
ously proposed mechanism that focuses on the specific disruption of
protective intermolecular interactions in alpha-synuclein, also a
more general mechanism that involves the stability of any
aggregation-prone protein may apply. Next to hydrophobicity and
beta sheet propensity, net charge is a critical determinant for the
behavior of proteins in solution, because charge repulsion between
molecules is essential to keep proteins uniformly distributed. This
phenomenon is known as colloidal stability and strongly determined
by the charge distribution of the molecules (Garidel et al, 2015;
Thompson et al, 2016). Neutralization of charged regions—as
occurs in the presence of mutations, modifications, or modifiers
such as SERF—could result in reduced charge repulsion between
amyloid proteins and lower the colloidal stability of the proteins in
solution, thus accelerating fibril formation. Colloidal stability has
also been shown to be important for liquid–liquid phase separation,
A B C
D E F
Figure 7. Charge rather than amino acid composition of MOAG-4/SERF drives binding to amyloidogenic proteins and aggregation.
A Mutations and average net charge distribution of wild-type SERF2 (reused from Fig 4A) and SERF2 KR mutant. Wild-type SERF2 and KR mutant sequences are
shown, and mutations are indicated in red.
B, C Microscale thermophoresis (MST) analysis of wtSERF2, SERF2 charge mutant, and KR mutant binding to the strongest identified wild-type SERF2 binding peptide
from alpha-synuclein (B) and amyloid beta (C). Binding is represented as the ΔFnorm, the normalized difference in relative fluorescence between a specific sample
and the baseline (the binding intensity without peptide). Data are represented as mean  SD, n = 4 biological replicates.
D KD values for each interaction quantified from the experiments depicted in (B) and (C). Data are represented as mean  SD, n = 4 biological replicates. Significance
was determined using a two-way ANOVA followed by Tukey’s multiple comparisons test *P-value < 0.05 and ****P-value < 0.0001.
E Mutations and average net charge distribution of wild-type MOAG-4 (reused from Fig 6A) and MOAG-4 KR mutant, MOAG-4 sequences are shown, and mutations
are indicated in red.
F Representative quantification of the number of aggregates in Q40 worms with moag-4 deletion or expression of either wild-type moag-4, moag-4 charge mutant,
moag-4 ctrl mutant, or moag-4 KR mutant. The results shown are representative experiments of three biological replicates of n = 20 worms in L4 stage. Data are
represented as mean  SD, and significance was calculated using a one-way ANOVA followed by a Bonferroni post hoc multiple comparisons test. ****P < 0.0001.
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where proteins are present in high concentrations in membrane-less
cellular compartments (Shin & Brangwynne, 2017). Mutations, post-
translational modifications, or environmental factors that result in
imbalances in colloidal stability—including charge alteration—could
initiate a liquid-to-solid transition toward aggregate-like structures,
a transition that resembles the process of amyloid formation (Mol-
liex et al, 2015; Pak et al, 2016; Ray et al, 2020). A third possibility
is the existence of other activities of SERF2 that are initiated by elec-
trostatic interactions between SERF2 and amyloid-forming proteins.
Additional research is required to distinguish which mechanisms
apply for SERF2 in the presence of amyloidogenic proteins.
Why SERF acts as an amyloid-promoting factor is not known.
Misfolded monomeric and oligomeric species are generally consid-
ered to be the toxic species in age-related disease. A low-energy
sequestration mechanism that quickly removes and compactly stores
unwanted aggregation-prone proteins could therefore be beneficial.
It is possible that under healthy conditions, SERF’s function is part of
such a sequestration mechanism, whereby it drives transitions of
aggregation-prone proteins toward an amyloid state. Alternatively,
the aggregation-promoting effect of MOAG-4/SERF2 in the presence
of aggregation-prone disease proteins could be an unwanted side
effect of a different function. For example, a role for SERF1A as an
RNA chaperone in the formation of liquid-like RNA organelles has
been suggested (Meyer et al, 2020). Since both RNA and alpha-
synuclein are known to interact with the positively charged N-
terminal region of SERF, they might compete for this SERF binding
site, possibly favoring alpha-synuclein–SERF interactions and addi-
tional amyloid formation under stress conditions (Meyer et al, 2020).
Meyer et al (2020) findings, together with the previously shown toxic
effects of SERF2 in the presence of amyloid proteins (Van Ham et al,
2010), could suggest that the amyloid-promoting properties of SERF2
are a function that is induced under stress conditions.
Based on our results and those of recently published studies on
SERF1A and ScSERF, we propose a mechanistic model in which
charge complementation by SERF accelerates the primary nucleation
of amyloid. Our finding that simply changing the charge of the
endogenous SERF in C. elegans was sufficient to have a profound
effect on protein aggregation and toxicity indicates a critical role for
charge complementation in the regulation of proteome stability.
Taken together, our results suggest that preventing charge interac-
tions between aggregation-prone proteins and charged cellular
modifiers deserves exploration as a strategy to prevent or delay the
onset of protein toxicity in aging and age-related diseases.
Materials and Methods
Microarray peptide screen
For SERF2-peptide binding determination, custom-made microar-
rays were purchased from PEPperPRINT (PEPperCHIP® Peptide
Microarray, PEPperPRINT). For the production of the microarrays,
12-mer peptides were directly synthesized on poly(ethylene glycol)-
based graft copolymer-coated glass slides with a three amino acid
linker (ß-alanine, aspartic acid, and ß-alanine), using an established
peptide laser printing technology (Stadler et al, 2008). Peptides were
synthesized from C- to N-terminus, yielding peptides with free
N-termini, and C-termini coupled to the slide through the
aforementioned linker. In brief, each activated amino acid, covered
at its N-terminus by a 9-fluorenylmethoxycarbonyl (Fmoc) protec-
tion group, was separately attached with its C-terminus to the three
amino acid linker or its neighboring amino acid through a cycle
composed of a melting (coupling) step, removal of excessive mono-
mers, and removal of the Fmoc protection group. This cycle was
repeated until all peptides were synthesized. All 12-mer peptides
were present in duplicate and randomly distributed on each half of a
slide. All experiments were performed using the HS 400TM Pro
Hybridization Station and HS Pro control manager software (Tecan).
The slides were washed with Milli-Q three times for 1 min with 30 s
of soak time, followed by washing with binding buffer (1× PBS,
0.05% Tween, pH 7.4) three times for 1 min with 30 s of soak time.
Slides were blocked with blocking buffer (1% BSA, 1× PBS, 0.05%
Tween, pH 7.4) for 30 min with medium agitation frequency. Slides
were incubated with 1 µM ATTO633-labeled wild-type or charge
mutant SERF2 proteins in binding buffer for 1 h with medium agita-
tion frequency. After incubation, the slides were washed with wash-
ing buffer (1× PBS, 0.1% Tween, pH 7.4) three times for 2 min with
30 s of soak time, followed by washing with binding buffer three
times for 2 min with 30 s of soak time. The slides were then washed
with Milli-Q three times for 1 min with 30 s of soak time, and dried
with nitrogen for 2 min. The viscosity during all steps was set to
medium, and all steps were performed at 25°C. The slides were
imaged and analyzed using the PowerScanner Microarray and Array-
Pro® Analyzer software (Tecan) with wavelengths channel 1: 580/
30 nm and channel 2: 676/37 nm, 200% gain, and 1% laser power.
Slides were regenerated in between experiments. For regeneration,
slides were incubated in regeneration buffer (100 mM glycine,
500 mM NaCl, 6 M Gua-HCl, pH 2.0) while sonicated in a water bath
at room temperature for 90 min. The slides were left overnight in
regeneration buffer in the water bath at room temperature. Subse-
quently, slides were sonicated again for 30 min at 50°C. After sonica-
tion, the slides were washed five times with Milli-Q, five times with
absolute ethanol, and three times with acetone. Slides were dried
using air flow and imaged using the Powerscanner Microarray as
described above to confirm the slides were fully regenerated.
Microarray data analysis
All peptides on the microarray were classified as SERF2 “binders”,
“non-binders”, or “ambiguous” as follows. For each experiment, a
cutoff value distinguishing binder from non-binder peptides was
calculated as the mean RFU of the Gly control peptides plus two
times the standard deviation of the RFU signals of the Gly control
peptides, as shown in Fig 1B. Assuming an approximately normal
distribution for the binding signal to Gly control peptides, this cutoff
would encompass 97.5% of the control peptide population, indicat-
ing that peptides with higher RFU signals likely do not belong to the
background population and are in fact true binders. Per experiment,
a peptide was classified as a binder for that experiment if both of its
duplicates on the microarray showed higher binding intensities than
the cutoff value (Dataset EV1). Peptides for which this was not the
case were considered non-binders for that experiment. Finally, only
peptides that fulfilled the binder criterion in each of the three repeat
experiments were withheld as actual binders. Peptides that consis-
tently fell below the cutoff value across three experiments were clas-
sified as non-binders. The remaining peptides, which show an
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inconsistent classification across three experiments, were classified
as “ambiguous” (Dataset EV2).
Next, amino acid enrichment scores—also referred to as ln(prob-
ability ratios)—in binding versus non-binding peptides were deter-
mined using the formula:
scoreaa ¼ ln proportion in bindersaaproportion in non  bindersaa
 
, with aa indicating each of
the 20 amino acids (Dataset EV3). Ambiguous peptides were not
considered in these analyses. Statistical significance of these enrich-
ments was determined through hypergeometric testing with the
Bonferroni correction for multiple comparisons. Using the enrich-
ment scores for each amino acid, we then produced a cumulative




scoreaa;i with scoreaa,i indicating the score for the
amino acid aa in position i of the peptide (Dataset EV2). The
performance of this cumulative score as a predictor for SERF2 bind-
ing was assessed through linear regression and ROC curve analysis
as indicated in the main text.
To assess how amino acid composition differs between binders
that deviate strongly from their predicted value based on the cumu-
lative scores and binders that do not, we identified a subset of
binders as “deviating” if their mean RFU values were more than two
standard deviations above the mean difference with the regression
curve across all data points (as shown in Fig 3A). We then repeated
the workflow above to identify enrichment scores, this time calcu-
lating deviant scores as follows: deviant scoreaa ¼ ln
proportion in deviating peptidesaa
proportion in non  deviating peptidesaa
 
with aa indicating each of the 20
amino acids (Dataset EV5).
To assess whether the peptide set on the microarray satisfactorily
represents peptides from the human cytoplasmic proteome, the
reviewed human proteome was retrieved from UniProt (proteome ID
UP000005640). Membrane proteins were filtered out from the protein
set based on the UniProt “Gene Ontology—subcellular localization”
annotation. 12-Mer peptides with an overlap of 8 residues were derived
from the remaining set of proteins as described in Main text and in Fig 1
A. Duplicate peptides were filtered out, and for the remaining peptide
set secondary structure propensities, hydrophobicity and net charge
were calculated using the Bio.SeqUtils.ProtParam python module.
For an overview of SERF2 binding sites along the primary
sequence of the proteins represented on the microarray, the average
binding intensity for the Gly control peptides was first subtracted
from the binding signals in each repeat experiment, yielding
background-corrected binding signals. Next, for each residue, the
average net charge and average binding intensity were calculated by
taking the average charge or intensity of all three 12-mer windows
in which this residue was represented. This resulted in average-
score patterns with a resolution of four amino acids as depicted in
Fig 2 and Appendix Fig S1B (Dataset EV4).
The analyses above were performed using a combination of
Python 3.6 (PyCharm IDE version 2018.1.2) and R statistical soft-
ware version 3.5.2 (IDE RStudio version 1.1.463).
In vitro aggregation assay
Alpha-synuclein thioflavin T (ThT) fluorescence measurements were
performed in triplicate as described previously (Falsone et al, 2012).
In brief, 50 µM alpha-synuclein was mixed with an equimolar
amount of SERF2 or SERF2 charge mutant in 50 mM Tris–HCl,
150 mM NaCl, and 3 mM NaN3 (alpha-synuclein working buffer, pH
7.4), and shaken at 1,400 rpm at 37°C. At the different time points,
5 µl aliquots were removed and diluted in 1 ml of a 5 µM ThT solu-
tion buffer (Sigma-Aldrich), and ThT fluorescence was measured on
a Jasco FP-6500 fluorescence spectrometer (Jasco GmbH, Pfungstadt,
Germany) at 25°C and 482 nm, upon excitation at 442 nm, in a 1 ml
quartz cuvette at 25°C. Ex/em slit widths = 10/10 nm.
Aggregation kinetic assays for amyloid beta and hIAPP were
performed as described previously (Aprile et al, 2017; Bongiovanni
et al, 2018). In brief, all measurements were performed in black,
low-binding 96-well half-area plates, with clear bottom (Corning).
Plates were sealed, and ThT fluorescence was measured at each
time point with an excitation wavelength of 440 nm and an emis-
sion wavelength of 480 nm at 37°C, using a CLARIOstar plate reader
(BMG Labtech). Measurements were performed in quadruplicate
and quintuplicate, without agitation. 1 µM amyloid beta was mixed
with 4 µM SERF2 or SERF2 charge mutant in 20 mM sodium phos-
phate buffer pH 8.0, 200 μM EDTA, and 0.02% NaN3, and supple-
mented with 20 μM ThT. 2 µM hIAPP was mixed with 8 µM SERF2
or SERF2 charge mutant protein in standard PBS.
Microscale thermophoresis (MST)
Peptides were synthesized in-house using an Intavis Multipep RSi
synthesizer following Fmoc/tBu solid-phase synthesis strategy.
Peptides were subsequently labeled with 5(6)-carboxyfluorescein as
described in the supplementary information.
Directly prior to the MST analysis, a peptide aliquot was dried,
resolubilized in 1,1,3,3-hexafluoroisopropanol, and dried again. The
resulting film was dissolved in DMSO and diluted 1:20 in 10 mM
Tris pH 7.6 prior, after which concentration was determined using a
NanoDrop (Thermo Fisher). Peptides were then diluted to a concen-
tration of 600 nM in 10 mM Tris pH 7.6 with 0.5% Tween-20.
SERF2 or mutants thereof were diluted to a concentration of 107 µM
in 10 mM Tris, and a 1:1 dilution series was produced. This dilution
series was then mixed at a 9:1 ratio with 600-nm peptide, resulting
in a final assay buffer of 10 mM Tris with 0.05% Tween-20 and a
final labeled peptide concentration of 60 nM. Thermophoresis was
then performed on a Monolith NT. Automated (NanoTemper,
Germany). KD determination was performed using the MO. Affinity
Analysis (NanoTemper, Germany) software version 2.3, using a KD
model and keeping the target concentration constant at 60 nM.
Filter Trap assay
The Filter Trap assay was performed as described previously (Wanker
et al, 1999). In brief, 2.5 × 106 SERF2 CRISPR deletion mutant cells
were cotransfected with 1,000 ng (mut)HA-74Q DNA and either
3,000 ng wild-type hSERF2-HA or mutant SERF2-HA DNA using
1 mg/ml polyethylenimine (PEI) reagent (Polysciences, 239662). Cells
were collected 16 h after transfection in FTA sample buffer (10 mM
Tris-Cl pH 8.0, 150 mM NaCl and 2% SDS) supplemented with
Complete Protease Inhibitor Cocktail (25×) (Roche; 11697498001).
Fast-prep treatment was performed 5 × 20 s at 4 m/s (MP Biomedi-
cals; 116004500). Total protein was quantified using a PierceTM BCA
Protein Assay Kit (Thermo Fisher Scientific; 23225). The dilution
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range was 40 µg, 8 µg, and 1.6 µg in 100 µl FTA sample buffer supple-
mented with 1 M DTT (1:20) (Sigma; D0632), and incubation was at
95°C for 5 min. A Bio-Dot apparatus (Bio-Rad) was used to trap the
aggregates in a 0.2 micron cellulose acetate membrane (Sterlitech;
CA023001). Membrane blocking in 5% milk in PBS-T 0.1%, antibody
staining, and membrane developing were performed as described
above for Western blotting. The antibodies used to detect HA-tagged
polyQ74 were primary anti-HA antibody-ChIP Grade (1:5,000; Abcam;
ab9110), or primary anti-polyglutamine antibody (1:1,000; Sigma-
Aldrich, P1874) in 5% milk in PBS-T 0.1%. Filter Trap results were
quantified using ImageJ. In addition, a Western blot was performed
with 50 µg protein of the cell lysates used for each Filter Trap, to quan-
tify protein expression in the different samples as described above for
Western blot. PolyQ74 was detected using primary anti-HA antibody-
ChIP Grade (1:5,000; Abcam; ab9110) or primary anti-polyglutamine
antibody (1:1,000; Sigma-Aldrich, P1874) in 5% milk in PBS-T 0.1%.
Anti-tubulin (Sigma-Aldrich; T6074) or anti-actin (MP Biomedicals;
08691001) was used as loading control at a 1:5,000 dilution.
Quantification of aggregates
The numbers of aggregates present in whole worms (L4 stage) were
counted using a fluorescence dissection stereomicroscope (Leica,
MZ16 FA). For each replicate, aggregates were counted in 20
animals. Statistical analysis was performed using GraphPad Prism 5.
One-way ANOVA and Bonferroni tests were used for comparisons.
P-values below 0.05 were considered statistically significant.
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. All data
are represented as mean  standard deviation.
Pathogen avoidance assay
Pathogen avoidance in C. elegans was assayed as previously
described (Pujol et al, 2001). In brief, 50 to 75 young adult
hermaphrodites of the desired strain were transferred to NGM-agar
plates seeded with pathogenic S. marcescens strain Db11 or non-
pathogenic E. coli OP50. The nematodes were kept for 24 h to sensi-
tize before being transferred to a fresh plate with the same bacterial
strain (groups of 10 to 15 nematodes to generate 4 to 5 replicates).
The location of the nematodes was analyzed after an additional
24 h. The avoidance index was calculated as the number of nema-
todes off the lawn over the total number of nematodes. Three inde-
pendent experiments were performed for the assay.
Fluorescence lifetime imaging microscopy
Day 4 old nematodes (strains JKM2, JKM3, PHX1099-JKM2, and
PHX1173-JKM2) were anesthetized with 250 mM NaN3 for up to
30 min, and mounted on an 2.5% agarose pad, and confocal micro-
scopy/fluorescence lifetime measurements were performed as
described (10).
Measurements were carried out using a “Leica SP5” confocal
microscope, objectives used were “HCX PL APO 63 × 1.2” and “HCX
PL APO CS 100 × 1.4”; zoom was applied up to 1.5-fold. Images were
recorded by time-correlated single photon counting (TSCPC) using
“PicoHarp 300” (PicoQuant). A pulsed supercontinuum laser was
used for excitation, emitting pulses at 80 MHz. An acousto-optic
beam splitter was used to set excitation light to 565 nm and to
measure emission between 575 and 625 nm. Photon count rates were
kept below 1% of the laser repetition rate to prevent photon pileup.
Images were acquired until approx. 3,500 photons per pixel were
recorded. Images were processed with “FlimFit” software (11) and
fitted assuming monoexponential decays.
Lifespan assay
Nematodes were age-synchronized by egg laying. Larvae were grown
for three days, and L4 larvae were transferred to assay plates in
cohorts of 30–35 animals. Approximately 100 nematodes were used
per assay and strain. Nematodes were cultured at 20°C and scored
every day. Survival was tested by gently prodding nematodes with a
platinum wire. The nematodes were transferred to fresh plates every
day until day 10. From then on, they were transferred every three
days. To compare the survival distributions of two groups, the log-
rank test (Mantel–Cox) was employed. JKM2 and N2 were analyzed
first to establish a baseline reference. Subsequently, lifespans of
PHX1099, PHX1173, PHX1099-JKM2, and PHX1173-JKM2 were
compared. To confirm the observed difference between PHX1099-
JKM2 and PHX1173-JKM2, a repeat experiment was performed.
Development assay
In order to obtain approximately 50 eggs per strain on fresh NGM
plates, around 5-10 adult nematodes of strains PHX1099, PHX1173,
JKM2, PHX1099-JKM2, and PHX1173-JKM2 were placed onto sepa-
rate NGM plates to lay eggs for 4 h at 20°C.
Eggs were incubated at 20°C for three days. Hatched larvae and
their corresponding larval stages were counted. Six cohorts were
analyzed for JKM2 to establish a baseline reference. Over the course
of two experimental runs, three cohorts were analyzed for PHX1099
and PHX1173 and six cohorts were analyzed for PHX1099-JKM2 and
PHX1173-JKM2. More details about procedures and reagents used in
this study, including descriptions of standard procedures to generate
and analyze cell lines, C. elegans strains, and purified proteins, and
amyloid-forming proteins versus proteome net charge analysis are
provided in the Appendix Materials and Methods.
Data availability
The datasets and computer code produced in this study are available
in the following databases:
• Dataset EV1: Position and raw intensity measurement of all
microarray peptides. Unishare (https://unishare.nl/index.php/s/
ggoGMt6Jdo85RFk)
• Dataset EV2: Peptide array binding calculations. Unishare
(https://unishare.nl/index.php/s/ggoGMt6Jdo85RFk)
• Dataset EV3: Enrichment scores per amino acid. Unishare
(https://unishare.nl/index.php/s/ggoGMt6Jdo85RFk)
• Dataset EV4: Per-residue average SERF2 binding, TANGO and
WALTZ scores, and net charge. Unishare (https://unishare.nl/
index.php/s/ggoGMt6Jdo85RFk)
• Dataset EV5: Enrichments of amino acids in binding peptides devi-
ating from prediction. Unishare (https://unishare.nl/index.php/s/
ggoGMt6Jdo85RFk)
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• Dataset EV6: Amyloid Growth Parameters. Unishare (https://
unishare.nl/index.php/s/ggoGMt6Jdo85RFk)
• Dataset EV7 C.elegans amyloid beta aggregation and toxicity
measurements. Unishare (https://unishare.nl/index.php/s/
ggoGMt6Jdo85RFk)
• R-script: used for the analysis of the Microarray peptide screen
(.html and .Rmd). Unishare (https://unishare.nl/index.php/s/
ggoGMt6Jdo85RFk)
Expanded View for this article is available online.
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